Norwich Pharmaceuticals breaks ground on $26 million expansion

NORWICH – A ceremonial groundbreaking was held at Norwich Pharmaceuticals on Tuesday, putting in motion a $26 million expansion project that company spokesmen say will make Norwich a more aggressive competitor in the world of pharmaceutical manufacturing.



In March, the company formally announced the undertaking – its single largest capitol investment since the plant was constructed in 1976. The scope of the project includes a 26,000 square foot building expansion (growing the structure size to a total 385,000 square feet) as well as acquisition and installation of new processing equipment which executives say will help the company keep pace with production demands coming down the pike.

Alvogen, the parent company of Norwich Pharmaceuticals, plans to have the project completed by fall, 2016.


There's more to this story! You're only seeing 27% of the story. Subscribe now to get immediate access to the rest of the story as well as our whole online offering.

Today's Other Stories



© 2017 Snyder Communications/The Evening Sun
29 Lackawanna Avenue, Norwich, NY 13815 - (607) 334-3276
pennysaver logo greatgetaways logo
We're on Facebook